Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BioVie Announces FDA Authorization Of Investigational New Drug Application For Phase 2 Trial To Evaluate Bezisterim In Long COVID; Authorization Puts Co. On Track To Receive Additional $12.6M Grand From US DOD And Initiate Phase 2 Trial

Author: Benzinga Newsdesk | September 03, 2024 08:01am

Posted In: BIVI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist